Extracorporeal membrane oxygenation (ECMO): extended indications for artificial support of both heart and lungs.
Extracorporeal membrane oxygenation (ECMO) was used to achieve temporary artificial support in cardiac and pulmonary function in 22 patients from 1987 to September 1990. Standard indications were postcardiotomy cardiogenic shock (n = 4), neonatal (n = 1) and adult respiratory distress syndrome (n = 4). ECMO was also used for extended indications, such as graft failure following heart (n = 11) or lung transplantation (n = 2). In six of these cases ECMO was instituted as a bridge device to subsequent retransplantation of either the heart (n = 4) or one lung (n = 2). One out of nine patients supported by ECMO for standard indications, and two out of 13 patients supported for extended indications are long-term survivors. This series illustrates the results with ECMO in emergency situations, in patients under immunosuppressive protocols, or in patients with advanced lung failure requiring almost complete artificial gas exchange. In such complex situations, ECMO does provide stabilization until additional therapeutic measures are in effect. ECMO cannot be recommended for postoperative cardiogenic shock but short-term ECMO support is an accepted method in most cases with graft failure or pulmonary failure or other origin.
Jurmann
M J
MJ
Division of Thoracic and Cardiovascular Surgery, Hannover Medical School, Germany.
Haverich
A
A
Demertzis
S
S
Schaefers
H J
HJ
Zahner
H H
HH
Endrigkeit
K D
KD
Wahlers
T
T
Cremer
J
J
Borst
H G
HG
D000328:Adult; D015199:Extracorporeal Membrane Oxygenation; D006084:Graft Rejection; D006333:Heart Failure / Q000628:therapy; D016027:Heart Transplantation; D006801:Humans; D007231:Infant, Newborn; D016040:Lung Transplantation; D012128:Respiratory Distress Syndrome / Q000628:therapy; D012770:Shock, Cardiogenic / Q000628:therapy